On the track of cell survival pharmaceuticals in the oligodendrocyte type-2 astrocyte lineage

Perspectives on Developmental Neurobiology

Volumn 3, Issue 2, 1996, Pages 121-131

  Noble, Mark ^a   Mayer Próschel, Margot ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Apoptosis; Cell survival; N acetyl L cysteine; Neurons; Oligodendrocytes; Trophic factors

Indexed keywords

ACETYLCYSTEINE; GLUTAMIC ACID; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; CELL LINE; CELL SURVIVAL; DRUG DESIGN; DRUG EFFECT; HUMAN; OLIGODENDROGLIA; PHYSIOLOGY; REVIEW;

ACETYLCYSTEINE; ANIMALS; CELL LINE; CELL SURVIVAL; DRUG DESIGN; GLUTAMIC ACID; HUMANS; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029684098     PISSN: 10640517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (125)

1. Raff, M.C. (1992). Social controls on cell survival and cell death. Nature 356, 397-400.
2. Johnson, E.M. Jr., Rich, K.M., and Yip, H.K. (1986). The role of NGF in sensory neurons in vivo. Trends Neurosci. 9, 33-37.
3. Barde, Y.-A. (1989). Trophic factors and neuronal survival. Neuron 2, 1525-1534.
4. Koseki, C. Herzlinger, D., and al-Awqati, Q. (1992). Apoptosis in metanephric development. J. Cell Biol. 119, 1327-1333.
5. Coles, H.S.R., Burne, J.F. and Raff, M.C. (1993). Large-scale normal death in the developing rat kidney and its reduction by epidermal growth factor. Development 118, 777-784.
6. Barres, B.A., Hart, I.K., Coles, H.C., Burne, J.F., Voyvodic, J.T., Richardson, W.D., and Raff, M.C. (1992). Cell death and the control of survival in the oligodendrocyte lineage. Cell 70, 31-46.
7. Louis, J.-C., Magal, E., Takayama, S., and Varon, S. (1993). CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259, 689-692.
8. Schubert, D., Kimura, H. and Maher, P. (1992). Growth factors and vitamin E modify neuronal glutamate toxicity. Proc. Natl. Acad. Sci. USA 89, 8264-8267.
9. Maiese, K., Boniece, I., DeMeo, D., and Wagner, J.A. (1993). Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J. Neurosci. 13, 3034-3040.
10. Matthews, W.B. (ed) (1991). McAlpine's Multiple Sclerosis, 2nd ed. Churchill Livingstone, London.
11. Dambska, M., Laure-Kamionowska, M., and Schmidt-Sidor, B. (1989). Early and late neuropathological changes in perinatal white matter damage. J. Child Neurol. 4, 291-2948.
12. van de Boor, M., Guit, G.L., Schreuder, A.M. Wondergem, J., and Vielvoye, G.J. (1989). Early detection of dDelayed myelination in preterm infants. Pediatrics 84, 407-411.
13. Leviton, A., and Paneth, N. (1990). White matter damage in preterm newborns - an epidemiologic perspective. Early Hum Dev. 24, 1-22.
14. Oka, A., Belliveau, M.J., Rosenberg, P.A., and Volpe, J.J. (1993). Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanism and perevention. J. Neurosci. 13, 1441-1453.
15. Raff, M.C., Barres, B.A., Burne, J.F, Coles, H.S., Ishizaki, Y., and Jacobsen, M.D. (1993). Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 262, 695-700.
16. Choi, D.W., and Rothman, S.M. (1990). The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 12, 171-182.
17. Meldrum, B., and Garthwaite, J. (1990). Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11, 379-387.
18. Kessler, M., Baudry, M., and Lynch, G. (1987). Use of cystine to distinguish glutamate binding from glutamate sequestration. Neurosci. Lett. 81, 221-226.
19. Zaczek, R., Balm, M., Artlis, S., Drucker, H., and Coyle, J.T. (1987). J. Neurosci. Res. 18, 425-431.
20. Meister, A., and Anderson, M.E.(1983). Glutathione. Annu Rev. Biochem. 52, 711-760.
21. Taniguchi, N., Higashi, T., Sakamoto, Y., and Meister, A. (1989). Glutathione Centennial: Molecular Properties and Clinical Implications. Academic Press, New York.
22. Selmaj, K.W., and Raine, C.S. (1988). Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23: 339-346.
23. Merrill, J.E. (1991). Effects of interleukin-1 and tumor necrosis factor-α on astrocytes, microglia, oligodendrocytes and glial precursors in vitro. Dev. Neurosci. 13, 130-137.
24. Hofman, P.M., von Hanwehr, R.I., Dinarello, CA., Mizel, S.B., Hinton, D., and Merrill, J.E. (1986). Immunoregulatory molecules and IL2 receptors identified in multiple sclerosis brain. J. Immunol. 136: 3239-3245.
25. Selmaj, K., Raine, C.S., Canella, B., and Brosnan, C.F. (1991). Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87: 949-954.
26. Wong, G.H.W., Elwell, J.H., Oberley, L.W., and Goeddel, D.V. (1989). Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58, 923-931.
27. Schulze-Osthoff, K., Bakker, A.C., Vanhaesebroeck, B. Beyaert, R., Jacobs, W., and Fiers, W. (1992). Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem. 267, 5317-5323.
28. Schulze-Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G., and Fiers, W. (1993). Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene inductive effects of TNF. EMBOJ. 12, 3095-3104.
29. Beutler, B., Milsark, I.W., and Cerami, A. (1985). Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 867-869.
30. Beutler, B., Greenwald, D., Kulmes, J.D., Chang, M., Pan, Y.-C.E., Mathison, J., Ulevitch, R., and Cerami, A. (1985). Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316, 552.
31. Piguet, P.-F., Grau, G.E., Allet, B., and Vassalli, P. (1987). Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J. Exp. Med. 166, 1280-1289.
32. Tracey, K.J., Wei, H., Manogue, K.R., et al (1987). Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation. J. Exp. Med. 167, 1211-1227.
33. Waage, A., Halstensen, A., and Espevik, T. (1987). Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet, 355-357.
34. Sherry, B., and Cerami, A. (1988). Cachectin/tumor necrosis factor exerts endocrine, paracrine and autocrine control of inflammatory responses. J. Cell Biol. 107, 1269-1277.
35. Munker, R., Gasson, J., Ogawa, M., and Koeffler, H.P.(1986). Recombinant TNF induces production of granulocyte-macrophage colony stimulating factor. Nature 323, 79-81.
36. Vogel, S.N. Doudes,S.D., Kaufman, E.N., and Neta, R. (1987). Induction of colony stimulating factor in vivo by recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha. Immunol. 138, 2143-2148.
37. Slungaard, A., Vercellotti, G.M., Walker, G., Nelson, R.D., and Jacob, H.S. (1990). Tumor necrosis factor-a/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J. Exp. Med. 171, 2025-2041.
38. Carswell, F.A., Old, L.J., Kassel, R.L. et al (1975). An endotoxinderived serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666-3670.
39. Sugarman, B.J. Aggarwal, B.B., Hass, P.E., Figari, I.S., Palladino, M.A., Jr., and Shepard, H.M. (1985). Recombinant tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230, 943-945.
40. Beutler, B., and Cerami, A. (1988). Tumor necrosis factor, cachexia, shock and inflammation: a common mediator. Annu. Rev. Biochem. 57, 505-518.
41. Old, L.J. (1988). Tumor necrosis factor. Sci. Am. 258(5), 59-75.
42. Tracey, K.J., Beutler, B., Lowry, S.F., et al (1986). Shock and tissue injury induced by recombinant human cachectin. Science 234, 470-474.
43. Starnes, H.F., Jr., Warrewn, R.S., Jeevanandam, M., Gabriloue, J.L., Larchian, W., Oettigen, H.F., and Brennan, M.F. (1988). Tumor necrosis factor and the acute metabolic response to tissue injury in man. J. Clin. Invest. 82, 1321-1325.
44. Michie, H.R., Spriggs, D.R., Manogue, K.R., et al (1988). Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104, 280-286.
45. Michie, H.R., Manogue, K.R., Spriggs, D.R., Revhau, A., O'Dwyer, S., Dinarello, C.A., Cerami, A., Wolff, S.M., and Wilmore, D.W. (1988). Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318, 1481-1486.
46. Suva, A.T., Bayston, K.P., and Cohen, J. (1990). Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram negative shock. J. Infect. Dis. 162, 421-427.
47. Girardin, Grau, G.E., Dayer, J.M., Roux-Lombard, P., and Lambert, P.H. (1988). Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319, 397-400.
48. Debets, J.M.H., Kempmeijer, R., van der Linden, M.P., Bourman, W.A. and van der Linden, C.J. (1989). Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit. Care Med. 17, 489-494.
49. Aruoma, O.I., Halliwell, B., Hoey, B.M., and Butler, J. (1989). The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, Superoxide and hypochlorous acid. Free Radic. Biol Med. 6, 593-597.
50. Burgunder, J.M., Varriale, A., and Lauterburg, B.H. (1989). Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur. J. Clin. Pharmacol. 36, 127-131.
51. Smilkstein, M.J., Knapp, G.L., Kulig, K.W., and Rumack, B.H. (1988). Efficancy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N. Engl. J. Med. 319, 1557-1562.
52. Anker, A.L., and Smilkstein, MJ. (1994). Acetaminophen. Concepts and controversies. Emerg. Med. Clin. North Am. 12, 335-349.
53. Wells, W.W., Xu, D.P., Yang, Y., and Rocque, P.A. (1990). Mammalian thiol transferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J. Biol. Chem. 265, 15361-15364.
54. Mårtensson, J., Jain, A., Stole, E., Frayer, W., Auld, P.A., and Meister, A. (1991). Inhibition of glutathione synthesis in the newborn rat: A model for endogenously produced oxidative stress. Proc. Natl. Acad. Sci. USA 89, 9360-9364.
55. Mårtensson, J., and Meister, A. (1991). Glutathione deficiency decreases tissue ascorbate levels in newborn rats: Ascorbate spares glutathione and protects. Proc. Natl. Acad. Sci. USA 88, 4656-4660.
56. Fishman, C.H., Udey, M.C., Kurtz, M., and Wedner, J.J. (1981). Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: Decreased intracellular glutathione inhibits and early event in the activation sequence. J. Immunol. 127, 2257.
57. Fidelus, R.K., and Tsan, M.F. (1986). Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen. Cell. Immunol. 97, 155-160.
58. Fidelus, R.K., Ginouves, P., Lawrence, D., and Tsan, M.F. (1987). Modulation of intracellular glutathione concentrations alters lymphocyte activation and proliferation. Exp. Cell Res. 170, 269.
59. Fidelus, R.K. (1988). The generation of oxygen radicals: a positive signal for lymphocyte activation. Cell Immunol. 113, 175-181.
60. Merrill, J.E. (1991). Effects of interleukin-1 and tumor necrosis factor-a on astrocytes, microglia, oligodendrocytes and glial precursors in vitro. Dev. Neurosci. 13, 130-137.
61. Eylar, E., Rivera-Quinones, C., Molina, C., Baez, I., Molina, F., and Mercado, C.M. (1993). N-acetylcystein enhances T cell functions and T cell growth in culture. Int. Immunol. 5, 97-101.
62. Suthanthiran, M., Anderson, M.E., Sharma, V.K., and Meister, A. (1990). Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. USA 87, 3343-3347.
63. Hamilos, D.L., and Wedner, J.J. (1985). The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation. J. Immunol. 135, 2740-2745.
64. Hamilos, D.L., Zelarney, P., and Mascali, J.J. (1989). Lymphocyte proliferation in glutathione-depleted lymphocytes: direct relationship between glutathione availability and the proliferative response. Immunopharmacology 18, 223-235.
65. Droge, W., Pottmeyer-Gerber, C., Schmidt, H., and Nick, S. (1986). Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology 172, 151-159.
66. Meister, A., Anderson, M.E., and Hwang, O. (1986). Intracellular cysteine and glutathione delivery systems. J. Am. Coll. Nutr. 5, 137-151.
67. Anderson, M.E., and Meister, A. (1989). Glutathione monoesters. Anal. Biochem. 183, 16-20.
68. Martensson, J., and Meister, A. (1989). Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proc. Natl. Acad. Sci. USA 86, 471-475.
69. Vina, J., Perez, C., Furukawa, T., Palacin, M., and Vina, J.R. (1989). Effect of oral glutathione on hepatic glutathione levels in rats and mice. Br. J. Nutr. 62, 683-691.
70. Roederer, M., Staal, F.J.T., Raju, P.A., Ela, S.W., Herzenberg, L.A., and Herzenberg, L.A. (1990). Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc. Natl. Acad. Sci. USA 87, 4884-4888.
71. Roederer, M., Stall, F.J.T., Osada, H., Herzenberg, L.A., and Herzenberg., L.A. (1991). CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Int. Immunol. 3, 933-937
72. Roederer, M., Raju, P.A., Staal, F.J.T., Herzenberg, L.A., and Herzenberg, L.A. (1991). N-acetylcysteine inhibits latent HIV expression in chronically-infected cells. AIDS Res. Hum. Retroviruses 7, 491-496.
73. Roederer, M., Ela, S.W., Staal, F.J., Herzenberg, L.A., and Herzenberg, L.A. (1992). N-acetylcysteine: a new approach to anti-HIV therapy. AIDS Res. Hum. Retroviruses 8, 209-217.
74. Staal, F.J.T., Roederer, M., Herzenberg, L.A., and Herzenberg, L.A. (1990). Intracellular thiols regulate NF-κB activation and HIV transcription. Proc. Natl. Acad. Sci. USA 87, 9943-9947.
75. Staal, F.J., Roederer, M., Raju, P.A., Anderson, M.T., Ela, S.W., Herzenberg, L.A., and Herzenberg, L.A. (1993). Antioxidants inhibit stimulation of HIV transcription. AIDS Res. Hum. Retroviruses 9, 299-306.
76. Mihm, S., Ennen, J., Pessara, U., Durth, R., and Droge, W. (1991). Inhibition of HIV-1 replication and NF-kappaB activity by cysteine and cysteine derivatives. AIDS 5, 497.
77. Lioy, J., Ho, W.Z., Cutilli, J.R., Polin, R.A., and Douglas, S.D. (1993). Thiol suppression of human immunodeficiency virus type 1 replicaton in primary cord blood monocyte-derived macrophages in vitro. J. Clin. Invest. 91, 495-498.
78. Kosower, N.S., Kosower, E.M., Wertheim, B., et al (1969). Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide. Biochem. Biophys. Res. Commun. 37, 593-596.
79. Kalebic, T., Kinter, A., Poli, G., Anderson, M.E. Meister, A., and Fauci, A.S. (1991). Suppression of HIV expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc. Natl. Acad. Sci. USA 88, 986.
80. Schreck, R., Rieber, P., and Bauerle, P.A. (1991). Reactive oxygen intermediates as apparently widely used messengers in activation of the NF-kappaB transcription factor and HIV-1. EMBO J. 10, 2247.
81. Ghosh, S., and Baltimore, D. (1990). Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature 344, 678-682.
82. Nabel, G., and Baltimore, D. (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713.
83. Duh, E.J., Maury, W.J., Folks, T.M., Fauci, A.S., and Rabson, A.B. (1989). Tumor necrosis factor activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa b binding sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86, 5974-5978.
84. Osborn, L., Hesslon, C., Tizaard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., and Lobb, R. (1989). Direct expression cloning of a vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59, 1203.
85. Schreck, R., and Baeuerle (1991). A role for oxygen radicals as second messengers. Trends Cell. Biol. 1, 39-42.
86. Klebanoff, S.J., Vadas, M.A., Harlan, J.M., Sparks, L.H., Gamble, J.R., Agosti, J.M., and Waltersdorph, A.M. (1986). Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136, 4220.
87. Nathan, C.F. (1987). Neurophil activation on biological surfaces: Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 80, 1550.
88. Kapp, A., Zeck-Kapp, G., and Blohm, D. (1989). Human tumor necrosis factor is a potent activator of the oxidative metabolism in human polymorphonuclear neutrophilic granulocytes: Comparison with human lymphotoxin. J. Invest. Dermatol. 92, 348.
89. Bilzer, M., and Lauterburg, B.H. (1991). Glutathione metabolism in activated human neutrophils: Stimulation of glutathione synthesis and consumption of glutathione by reactive oxygen species. Eur. J. Clin. Invest. 21, 316.
90. Zimmerman, R.J., Chan, A., and Leadon, S.A. (1989). Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res. 49, 1644.
91. Zimmerman, R.J., Marafino, B.J., Jr., Chan, A., Landre, P., and Winkelhake, J.L. (1989). The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. Implications for mechanisms of action. J. Immunol. 142, 1405.
92. Mayer, M., Bhakoo, K., and Noble, M. (1994). Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120, 143-153
93. Barres, B.A., Schmid, R., Sendtner, M., and Raff, M.C. (1993). Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118, 283-295.
94. Wyllie, A.H., Kerr, J.F.R., and Currie, A.R. (1980). Cell death: The significance of apoptosis. Int. Rev. Cytol. 68, 251-273.
95. Dolkart-Gorin, P., and Johnson, E.M. (1979). Experimental autoimmune model of nerve growth factor deprivation: Effects on developing peripheral sympathetic and sensory neurons. Proc. Natl. Acad. Sci. USA 76, 5382-5386.
96. Johnson, E.M., Jr., Gorin, P.D., Brandeis, L.D., and Pearson, J. (1980). Dorsal root ganglion neurons are destroyed by exposure in utero to maternal Antibodies to Nerve Growth Factor. Science 219, 916-918.
97. Carroll, S.L., Silos-Santiago, I., Frese, S.E., Ruit, K.G., Milbrandt, J., and Snider, W.D. (1992). Dorsal root ganglion neurons expressing trk are selective to NGF deprivation in utero. Neuron 9, 779-788.
98. Ruit, K.G., Elliott, J.L., Osborne, P.A., Van, Q., and Snider, W.D. (1992). Selective dependence of mammalian dorsal root ganglion neurons on nerve growth factor during embryonic development. Neuron 8, 573-587.
99. Gratzner, H.G. (1982). Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 318, 474-475.
100. Raffioni, S., Bradshaw, R.A., and Buxser, S.E. (1993). The receptors for nerve growth factor and other neurotrophins. Annu. Rev. Biochem. 62, 823-850.
101. Fantl, W.J., Johnson, D.E., and Williams, L.T. (1993). Signalling by Receptor tyrosine kinases. Annu. Rev. Biochem. 62, 453-481.
102. Stahl, N., and Yancopoulos G.D. (1993). The alphas, betas, and kinases of cytokine receptor complexes. Cell 74, 587-590.
103. Ip, N.Y., Nye, S.H., Boulton, T.G., Davis, S., Taga, T., Li, Y., Birren, S.J., Yasukawa, K., Kishemoto, T., Anderson, D.J., Stahl, N., and Yancopoulos G.D. (1992). CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell, 69, 1121-1132.
104. Bruckner, P., Horler, I., Mendier, M., Houze, Y., Winterhalter, K.H., Eich-Bender, S.G., and Spycher, M.A. (1989). Induction and prevention of chondrocyte hypertrophy in culture. J. Cell. Biol. 109, 2537-2545.
105. Tschan, T., Hoerler, I., Houze, Y., Winterhalter, K.H., Richter, C., and Bruckner, P. (1990). Resting chondrocytes in culture survive without growth factors, but are sensitive to toxic oxygen metabolites. J. Cell Biol. 111, 257-260.
106. Ihizaki, Y., Burne, J.F. and Raff, M.C. (1993). Autocrine signals enable chondrocytes to survive in culture. J. Cell Biol. 126, 1069-1077.
107. Sampath, D., Jackson, G.R., Werrbach-Perez, K., and Perez-Polo, J.R. (1994). Effects of nerve growth factor on glutathione peroxidase and catalase in PC12 cells. J. Neurochem. 62, 2476-2479.
108. Jackson, G.R, Sampath, D., Werrbach-Perez, K., and Perez-Polo, J.R. (1994). Effects of nerve growth factor on catalase and glutathione peroxidase in a hydrogen peroxide-resistant pheochromocytoma subclone. Brain Res. 634, 69-76.
109. Pan, A., and Perez-Polo, R. (1993). Role of nerve growth factor in oxidant homeostasis: glutathione metabolism. J. Neurochem. 61, 1713-1721.
110. Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
111. Kane, D.J., Sarafian, T.A., Anton, R., Hahn, H., Gralla, E.B., Valentine, J. S., Ord, T., and Bredesen, D.E. (1993). Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262, 1274-1277.
112. DeVries, N., and DeFlora, S. (1993). N-acetyl-L-cysteine. J. Cell. Biochem. Suppl. 17F, 270-277.
113. Suter, P.M., Domenighetti, G., Schauer, M.D., Laverriere, M.C., Ritz, R., and Perret, C. (1994). N-acetylcysteine enhances recovery from acute lung injury in man. A randomized double-blind, placebo-controlled clinical study. Chest 105, 190-194.
114. Beloqui, O., Prieto, J., Suarez, M., Gil, B., Qian, C.H., Garcia, N., and Civeira, M.P. (1993). N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: A pilot study. J. Interferon Res. 13, 279-282.
115. Balansky, R.B., D'Agostini, F., Zanacchi, P., and De Flora, S. (1992). Protection by N-acetylcysteine of the histopathological and cytogenetical damage produced by exposure of rats to cigarette smoke. Cancer Lett. 64, 123-131.
116. Izzotti, A., Balansky, R.M., Coscia, N., Scatolini, L., D'Agostini, F., and De Flora, S. (1992). Chemoprevention of smoke-related DNA adduct formatin in rat lung and heart. Carcinogenesis 13, 2187-2190.
117. De Flora, S. Izzotti, A., D'Agostini, F., Rossi, G.A., and Balansky, R.M. (1993). Pulmonary alveolar macrophages in molecular epidemiology and chemoprevention of cancer. Environ. Health Perspect. 99, 249-252.
118. Ruse, G.G., Larsson, S., Larsson, P., Jeansson, S., and Andersson, B. A. (1994). The intrabronchial microbial flora in chronic bronchitis patients: A target for N-acetylcystein therapy? Eur. Respir. J. 7, 94-101.
119. Ornaghi, F., Ferrini, S., Prati, M., and Giavini, E. (1993) The protective effects of N-acetyl-L-cystein against methyl mercury embryo-toxicity in mice. Fundam. Appl. Toxicol. 20, 437-445.
120. Zhang, H., Spapen, H., Nguyen, D.N., Benlabed, M., Buurman, W.A., and Vincent, J.L. (1994). Protective effects of N-acetyl-L-cystein in endotoxemia. Am. J. Physiol. 266, H1746-1754.
121. Lehmann, D., Karussis, D., Misrachi-Kill, R., Shezen, E., Ovadia, H., and Abramsky, O. (1994). Oral adminsitration of the oxidant-scavenger N-acetyl-L-cysteine inhibits acute experimental autoimmune encephalomyelitis. J. Neuroimmunol. 50, 35-42.
122. Leff, J.A., Wilke, C.P., Hybertson, B.M., Shanley, P.P., Beehler, C.J., and Repin, I.E. (1993). Postinsult treatment with N-acetyl-L-cysteine decreases IL-1 induced neutrophil influx and lung leak in rats. Am J. Physiol. 265, L501-506.
123. Sastre, J., Asensi, M., Rodrigo, F., Pallardo, F.V., Vento, M., and Vina, J. (1994). Antioxidant administration to the mother prevents oxidative stress associated with birth in the neonatal rat. Life Sci. 54, 2055-2059.
124. Manome, Y., Datta, R., Taneja, N., Shafman, T., Bump, E., Hass, R., Weichselbaum, R., and Kufe, D. (1993). Conduction of c-jun expression and internucleosomal DNA fragmentation by ionizing radiation. Biochemistry 32, 10607-10613.
125. Barale, R., Micheleti, R., Sbrana, C., Glussich, I., Scapoli, C., and Barrai, I. (1993). N-acetylcysteine inhibits diesel extract mutagenicity in the Ames test and SCE induction in human lymphocytes. Basic Life Sci. 61, 149-160.